• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 180NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 180NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 0500318E
Device Problem Fluid/Blood Leak (1250)
Patient Problems Hemorrhage/Bleeding (1888); Tachycardia (2095)
Event Date 10/13/2023
Event Type  malfunction  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
 
Event Description
A user facility registered nurse (rn) reported to fresenius that a dialyzer leak occurred during a patient's hemodialysis (hd) treatment.Additional information was obtained during follow-up with the clinic manager (cm) and the patient's hemodialysis registered nurse (hdrn).The reported issue was discovered toward the end of the patient¿s treatment.Fluid was noted to have accumulated on the outside of the lower lid of the dialyzer and was dripping.There was no defect or damage seen on the dialyzer.The patient¿s estimated blood loss was approximately 300 ml.The patient experienced tachycardia (approximated at 120 to 130 bpm) which was affirmed to be attributed to comorbidities unrelated to dialysis or the use of any fresenius product(s) or device(s).The patient was sent to the emergency department (ed) as a precaution despite being asymptomatic upon treatment completion.The patient was evaluated in the ed and released to home on the same day with no medical intervention or hospital admission.It was confirmed the patient did not experience a serious injury or adverse event requiring medical intervention as a result of the external blood leak.The patient continues hd therapy on an in-center basis without incident following this event.The dialyzer is available to be returned to the manufacturer for physical evaluation.
 
Event Description
A user facility registered nurse (rn) reported to fresenius that a dialyzer leak occurred during a patient's hemodialysis (hd) treatment.Additional information was obtained during follow-up with the clinic manager (cm) and the patient's hemodialysis registered nurse (hdrn).The reported issue was discovered toward the end of the patient¿s treatment.Fluid was noted to have accumulated on the outside of the lower lid of the dialyzer and was dripping.There was no defect or damage seen on the dialyzer.The patient¿s estimated blood loss was approximately 300 ml.The patient experienced tachycardia (approximated at 120 to 130 bpm) which was affirmed to be attributed to comorbidities unrelated to dialysis or the use of any fresenius product(s) or device(s).The patient was sent to the emergency department (ed) as a precaution despite being asymptomatic upon treatment completion.The patient was evaluated in the ed and released to home on the same day with no medical intervention or hospital admission.It was confirmed the patient did not experience a serious injury or adverse event requiring medical intervention as a result of the external blood leak.The patient continues hd therapy on an in-center basis without incident following this event.The dialyzer is available to be returned to the manufacturer for physical evaluation.
 
Manufacturer Narrative
Plant investigation: the reported complaint was not confirmed as the complaint device was not returned for manufacturer evaluation.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device.Therefore, the complaint is not confirmed.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas for vision systems and blood leak reduction are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 180NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key17995661
MDR Text Key326379550
Report Number0001713747-2023-00730
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100156
UDI-Public00840861100156
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K162488
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 11/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number0500318E
Device Lot Number23BU02008
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Initial Date Manufacturer Received 10/17/2023
Initial Date FDA Received10/24/2023
Supplement Dates Manufacturer Received11/16/2023
Supplement Dates FDA Received11/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/13/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES
Patient Age73 YR
Patient SexFemale
Patient Weight86 KG
-
-